While stem cells from bone marrow have become an established therapy for a handful of blood cancers - and while there are high hopes that the cells will someday lead to other major medical advances - critics say entrepreneurs are treating patients with little or no evidence that what they do is effective. George Daley, professor of biological chemistry and molecular pharmacology at Boston Children’s Hospital, is quoted.
